Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Short Interest Down 51.1% in March

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 50,500 shares, a decrease of 51.1% from the February 28th total of 103,300 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 609,700 shares, the short-interest ratio is currently 0.1 days.

Reckitt Benckiser Group Stock Performance

RBGLY stock traded up $0.20 during midday trading on Friday, reaching $13.56. The company had a trading volume of 183,173 shares, compared to its average volume of 336,059. The firm has a 50-day moving average price of $13.26 and a 200-day moving average price of $12.59. Reckitt Benckiser Group has a 1 year low of $10.24 and a 1 year high of $14.10. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47.

Reckitt Benckiser Group Increases Dividend

The company also recently declared a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 11th will be paid a dividend of $0.2909 per share. The ex-dividend date of this dividend is Friday, April 11th. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.19.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Barclays cut Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th. HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Royal Bank of Canada reissued an “outperform” rating on shares of Reckitt Benckiser Group in a report on Friday, March 7th. Finally, Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, December 11th. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat, Reckitt Benckiser Group presently has an average rating of “Buy”.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.